Agamon secures £2.4m Series A funding led by MMC Ventures to expand hospital deployments
The healthcare artificial intelligence startup raised the capital from backers including MMC Ventures, Seedcamp, and Bayer G4A to scale operations globally.
Agamon is a healthcare artificial intelligence startup that uses natural language understanding to transform unstructured clinical text into structured data. The company helps hospitals automate processes and track patient treatments more efficiently.
Healthcare artificial intelligence startup Agamon has secured £2.4m in a new funding round led by MMC Ventures. The financing also saw participation from InHealth Ventures, Seedcamp, and Bayer G4A.
Agamon plans to direct the fresh capital towards scaling its hospital deployments internationally and further training its artificial intelligence technology to broaden its clinical applications. The company already works with major healthcare providers, including Jefferson Health System and Henry Ford Health System.
From the founder
"The inability of today's computers to understand doctors' unique way of writing has been a major issue. Doctors can correctly describe an 'infiltrating mass' without writing the word 'tumor' or write 'bilateral ground glass peripheral opacity' without explicitly indicating a suspicion for COVID-19"
Michal Meiri
CEO and Co-founder at Agamon
Investor perspective
"We’re delighted to back Michal and the Agamon team as we continue to invest in data driven healthcare start-ups. We’re excited by Agamon’s ability to automate the interpretation of medical text and therefore enable products such as automatic follow up and patient friendly reports. Applications at the intersection of machine learning and healthcare data are helping drive much needed change in our healthcare systems and are a core part of our investment thesis at MMC."
Tom Moon
physician and investor, MMC Ventures
Use of funds
- 01Expand into international markets
- 02Fund research and development
